Skip to main content

ADVERTISEMENT

PD-L1

Research in Review
12/08/2016
JCP Editors
Patients with early stage metastatic non-small cell lung cancer (NSCLC) whose tumors express high levels of PD-L1 have improved quality of life with pembrolizumab treatment versus standard of care platinum-containing...
Patients with early stage metastatic non-small cell lung cancer (NSCLC) whose tumors express high levels of PD-L1 have improved quality of life with pembrolizumab treatment versus standard of care platinum-containing...
...
12/08/2016
Journal of Clinical Pathways